Application of fixed combinations in the treatment of arterial hypertension. Focus on ramipril and amlodipine

Author:

Maksimov M. L.ORCID, ,Shnaider K. O.ORCID,Kondrakhin A. P.ORCID, ,

Abstract

In modern algorithms of arterial hypertension treatment, the main strategic approach aimed at increasing the therapy effectiveness is the use of fixed combinations (FC) of two antihypertensive drugs at the start of therapy and of three drugs (preferably in one tablet) when it is necessary to intensify pharmacotherapy. Starting therapy with two drugs in one tablet (FC) is recommended for more than 70 % of patients. The article provides up-to-date information on the choice of a fixed combination for the treatment of patients with arterial hypertension (AH) according to modern national and international recommendations. The place of a fixed combination of ramipril and amlodipine among antihypertensive drugs in achieving the goal of treating patients with arterial hypertension was determined. The advantages of the fixed combination of ramipril and amlodipine due to the wide range of indications and its effectiveness for patients with hypertension in combination with chronic kidney disease (CKD) and metabolic syndrome are discussed. The distinctive properties of the fixed combination of ramipril and amlodipine are emphasized: it allows achieving target values of blood pressure (BP), improves adherence to treatment, reduces the frequency of prescribing additional antihypertensive drugs, and increases patient satisfaction with treatment. In patients with diabetes mellitus and metabolic syndrome, the fixed combination of ramipril and amlodipine allows achieving target values of blood pressure, promotes adherence to treatment, reduces heart rate, improves biochemical parameters of lipid and carbohydrate metabolism and functional kidney indicators. Ramipril, along with perindopril, is widely prescribed for patients with arterial hypertension, and its combination with amlodipine can be considered the method of choice in arterial hypertension patients with diabetes mellitus, chronic kidney disease, and metabolic syndrome.

Publisher

PANORAMA Publishing House

Subject

General Medicine,Applied Mathematics,General Mathematics,General Medicine,General Materials Science,Pharmacology (medical),General Medicine,General Medicine,Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology,General Medicine,General Earth and Planetary Sciences,General Environmental Science

Reference32 articles.

1. 1. Klinicheskaia farmakologiia i ratsionalnaia farmakoterapiia dlia praktikuiushchikh vrachei: uchebnik [Clinical pharmacology and rational pharmacotherapy for practitioners: textbook]/M. L. Maksimov, R.A. Bontsevich, I. S. Burashnikova [et al.]; ed. prof. M. L. Maksimov. - Kazan: Publishing House «MedDoc», 2021. - 948 p. (In Russ.)

2. 2. Renin-angiotenzin-aldosteronovaia sistema: monografiia [Renin-angiotensin-aldosterone system: monograph]/M. L. Maksimov, O.V. Dralova, D.O. Kurguzova [et al.]. - Moscow: Sechenov University Press, 2020. - 256 p. (In Russ.)

3. 3. Klinicheskie rekomendatsii RKO «Arterialnaia gipertenziia u vzroslykh» (utv. Min-zdravom Rossii, 2020) [Clinical recommendations of the RSC «Arterial hypertension in adults» (approved by the Ministry of Health of Russia, 2020)]. https://scardio.ru/content/Guidelines/2020/Clinic_rek_ AG_2020_unlocked. pdf. (In Russ.)

4. 4. Klinicheskie rekomendatsii RKO (proekt, 2022) «Arterialnaia gipertenziia u vzroslykh» [Clinical guidelines of the RSC (draft, 2022) «Arterial hypertension in adults»]. https://scardio.ru/content/Guidelines/project/KR_AG. pdf. (In Russ.)

5. 5. Ratsionalnaia farmakoterapiia arterialnoi gipertonii: uchebno-metodicheskoe posobie dlia vrachei [Rational pharmacotherapy of arterial hypertension: teaching aid for doctors]/M. L. Maksimov, A. S. Ermolaeva, N.M. Kiseleva, A.K. Starodubtsev. - Kazan: Publishing House «MedDoc» 2020. - 108 p. (In Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3